The neuroprotective action of naringenin on oseltamivir (Tamiflu) treated male rats

Ameer, 1997, Drug interactions with grapefruit juice, Clin. Pharmacokinet., 33, 103, 10.2165/00003088-199733020-00003 Amić, 2003, Structure radical scavenging activity relationships of flavonoids, Croat. Chem. Acta, 76, 55 Bezprozvanny, 2008, Neuronal calcium mishandling and the pathogenesis of Alzheimer’s disease, Trends Neurosci., 31, 454, 10.1016/j.tins.2008.06.005 Blanchard, 1998, Defensive behaviors in wild and laboratory (Swiss) mice: the mouse defense test battery, Physiol. Behav., 65, 201, 10.1016/S0031-9384(98)00012-2 Boyzo, 2003, Neuraminidase activity in different regions of the seizing epileptic and non-epileptic brain, Brain Res., 964, 211, 10.1016/S0006-8993(02)03985-9 Braff, 2001, Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia, Schizophr. Res., 49, 171, 10.1016/S0920-9964(00)00139-0 Cavia-Saiz, 2010, Antioxidant properties, radical scavenging activity and biomolecule protection capacity of flavonoid naringenin and its glycoside naringin: a comparative study, J. Sci. Food Agric., 90, 1238, 10.1002/jsfa.3959 Cheng, 2000, The ability of four flavonoids, baicilein, luteolin, naringenin, and quercetin, to suppress the Fenton reaction of the iron-ATP complex, Biometals, 13, 77, 10.1023/A:1009229429250 Chtourou, 2014, Protective effects of naringenin on iron-overload-induced cerebral cortex neurotoxicity correlated with oxidative stress, Biol. Trace Elem. Res., 158, 376, 10.1007/s12011-014-9948-0 Chtourou, 2015, Naringenin protects cardiac hypercholesterolemia-induced oxidative stress and subsequent necroptosis in rats, Pharmacol. Rep., 67, 1090, 10.1016/j.pharep.2015.04.002 Clementi, 1998, Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione, Proc. Natl. Acad. Sci. U.S.A., 95, 7631, 10.1073/pnas.95.13.7631 Crain, 2004, Neuraminidase inhibitor, oseltamivir blocks GM1 ganglioside-regulated excitatory opioid receptor-mediated hyperalgesia, enhances opioid analgesia and attenuates tolerance in mice, Brain Res., 995, 260, 10.1016/j.brainres.2003.09.068 Cui, 2014, Continual naringin treatment benefits the recovery of traumatic brain injury in rats through reducing oxidative and inflammatory alterations, Neurochem. Res., 39, 1254, 10.1007/s11064-014-1306-2 Da Silva, 2005, Asymmetric membrane ganglioside sialidase activity specifies axonal fate, Nat. Neurosci., 8, 606, 10.1038/nn1442 Darwish, 2012, Inhaled nitric oxide therapy fails to improve outcome in experimental severe influenza, Int. J. Med. Sci., 9, 157, 10.7150/ijms.3880 Dong, 2015, Naringin prevents carbon tetrachloride-induced acute liver injury in mice, J. Funct. Foods, 12, 179, 10.1016/j.jff.2014.11.020 Doostdar, 2000, Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1, Toxicology, 144, 31, 10.1016/S0300-483X(99)00215-2 Dou, 2013, Protective effect of naringenin against experimental colitis via suppression of Toll-like receptor 4/NF-jB signalling, Br. J. Nutr., 110, 599, 10.1017/S0007114512005594 Freeman, 2000, Omega-3 fatty acids in psychiatry: a review, Ann. Clin. Psychiatry, 12, 159, 10.3109/10401230009147106 Gerstner, 2011, Cytoplasmic to nuclear localization of fatty-acid binding protein correlates with specific forms of long-term memory in Drosophila, Commun. Integr. Biol., 4, 623, 10.4161/cib.16927 Golechha, 2014, Naringin ameliorates pentylenetetrazol-induced seizures and associated oxidative stress, inflammation, and cognitive impairment in rats: possible mechanisms of neuro-protection, Epilepsy Behav., 41, 98, 10.1016/j.yebeh.2014.09.058 Guix, 2012, Modification of γ-secretase by nitrosative stress links neuronal ageing to sporadic Alzheimer’s disease, EMBO Mol. Med., 4, 660, 10.1002/emmm.201200243 He, 1999, Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802, Clin. Pharmacokinet., 37, 471, 10.2165/00003088-199937060-00003 Hejl, 2004, Prepulse inhibition in patients with Alzheimer’s disease, Neurobiol. Aging, 25, 1045, 10.1016/j.neurobiolaging.2003.11.005 Hiasa, 2013, Inhibition of MAO-A and stimulation of behavioural activities in mice by the inactive prodrug form of the anti-influenza agent oseltamivir, Br. J. Pharmacol., 169, 115, 10.1111/bph.12102 Hsu, 2014, Ability of naringenin, a bioflavonoid, to activate M-type potassium current in motor neuron-like cells and to increase BKCa-channel activity in HEK293T cells transfected with α-hSlo subunit, BMC Neurosci., 15, 135, 10.1186/s12868-014-0135-1 Isaev, 2007, Role of extracellular sialic acid in regulation of neuronal and network excitability in the rat hippocampus, J. Neurosci., 27, 11587, 10.1523/JNEUROSCI.2033-07.2007 Izumi, 2008, Synaptic and behavioral interactions of oseltamivir (Tamiflu) with neurostimulants, Hum. Exp. Toxicol., 27, 911, 10.1177/0960327109102367 Jayaraman, 2012, Antiinflammatory role of naringenin in rats with ethanol induced liver injury, Toxicol. Mech. Methods, 22, 568, 10.3109/15376516.2012.707255 Jeon, 2001, Antioxidative activity of naringin and lovastatin in high cholesterol-fed rabbits, Life Sci., 69, 2855, 10.1016/S0024-3205(01)01363-7 Ju, 2005, Protective effects of S-nitrosoglutathione against amyloid beta-peptide neurotoxicity, Free Radic. Biol. Med., 38, 938, 10.1016/j.freeradbiomed.2004.12.019 Kacergius, 2006, Neuraminidase inhibitors reduce nitric oxide production in influenza virus-infected and gamma interferon-activated RAW264.7 macrophages, Pharmacol. Rep., 58, 924 Kamat, 2011, Mitochondrial dysfunction: a crucial event in okadaic acid (ICV) induced memory impairment and apoptotic cell death in rat brain, Pharmacol. Biochem. Behav., 100, 311, 10.1016/j.pbb.2011.08.019 Kerry, 1999, Inhibition of peroxynitrite-mediated oxidation of dopamine by flavonoid and phenolic antioxidants and their structural relationships, J. Neurochem., 73, 247, 10.1046/j.1471-4159.1999.0730247.x Khan, 2012, Naringenin ameliorates Alzheimer’s disease (AD)-type neurodegeneration with cognitive impairment (AD-TNDCI) caused by the intracerebroventricular-streptozotocin in rat model, Neurochem. Int., 61, 1081, 10.1016/j.neuint.2012.07.025 Kipp, 2011, Brain lipid binding protein (FABP7) as modulator of astrocyte function, Physiol. Res., 60, S49, 10.33549/physiolres.932168 Kokkinidis, 1976, Tolerance to damphetamine: behavioral specificity, Life Sci., 18, 913, 10.1016/0024-3205(76)90408-2 Kumar, 2010, Naringin alleviates cognitive impairment, mitochondrial dysfunction and oxidative stress induced by d-galactose in mice, Food Chem. Toxicol., 48, 626, 10.1016/j.fct.2009.11.043 Kwatra, 2016, Naringin and sertraline ameliorate doxorubicin-induced behavioral deficits through modulation of serotonin level and mitochondrial complexes protection pathway in rat hippocampus, Neurochem. Res., 41, 2352, 10.1007/s11064-016-1949-2 Liu, 1997, Expression of DA11, a neuronal-injury-induced fatty acid binding protein, coincides with axon growth and neuronal differentiation during central nervous system development, J. Neurosci. Res., 48, 551, 10.1002/(SICI)1097-4547(19970615)48:6<551::AID-JNR8>3.0.CO;2-9 Liu, 2004, Differential expression of duplicated genes for brain-type fatty acid binding proteins (fabp7a and fabp7b) during early development of the CNS in zebra fish (Danio rerio), Gene Expr. Patterns, 4, 379, 10.1016/j.modgep.2004.01.010 Liu, 2007, The fabp4 gene of zebrafish (Danio rerio) genomic homology with the mammalian FABP4 and divergence from the zebrafish fabp3 in developmental expression, FEBS J., 274, 1621, 10.1111/j.1742-4658.2007.05711.x Malinski, 2007, Nitric oxide and nitroxidative stress in Alzheimer’s disease, J. Alzheimers Dis., 11, 207, 10.3233/JAD-2007-11208 Marois, 2014, Inhibition of influenza virus replication by targeting broad host cell pathways, PLoS One, 9, e110631, 10.1371/journal.pone.0110631 Maurice, 1994, PRE-084, a α selective PCP derivative, attenuates MK-801- induced impairment of learning in mice, Pharmacol. Biochem. Behav., 49, 859, 10.1016/0091-3057(94)90235-6 Murtaugh, 1974, Evaluation of three influenza neuraminidase inhibition assays for use in a public health laboratory setting during the 2011-2012 influenza season, Public Health Rep., 128, 75 Nakao, 2001, Spatial performance correlates with long-term potentiation of the dentate gyrus but not of the CA1 region in rats with fimbria-fornix lesions, Neurosci. Lett., 307, 159, 10.1016/S0304-3940(01)01961-9 Oh, 2014, Role of bioactive food components in diabetes prevention: effects on beta-cell function and preservation, Nutr. Metab. Insights, 7, 51, 10.4137/NMI.S13589 Oldreive, 1998, Inhibition of nitrous acid-dependent tyrosine nitration and DNA base deamination by flavonoids and other phenolic compounds, Chem. Res. Toxicol., 11, 1574, 10.1021/tx980163p Owada, 1996, Spatio-temporally differential expression of genes for three members of fatty acid binding proteins in developing and mature rat brains, J. Chem. Neuroanat., 12, 113, 10.1016/S0891-0618(96)00192-5 Pingili, 2015, Pharmacokinetic interaction study between flavanones (hesperetin, naringenin) and rasagiline mesylate in Wistar rats, Drug Dev. Ind. Pharm., 30, 1 Rakers, 2014, Inhibitory potency of flavonoid derivatives on influenza virus neuraminidase, Bioorg. Med. Chem. Lett., 24, 4312, 10.1016/j.bmcl.2014.07.010 Raza, 2013, Neuroprotective effect of naringenin is mediated through suppression of NF-jB signaling pathway in experimental stroke, Neuroscience, 230, 157, 10.1016/j.neuroscience.2012.10.041 Reagan-Shaw, 2008, Dose translation from animal to human studies revisited, FASEB J., 22, 659, 10.1096/fj.07-9574LSF Rice-Evans, 1996, Structure-antioxidant activity relationship of flavonoids and phenolic acids, Free Radic. Biol. Med., 20, 933, 10.1016/0891-5849(95)02227-9 Richardson, 2000, The potential role of fatty acids in attention-deficit/hyperactivity disorder, Prostaglandins Leukot. Essent. Fatty Acids, 63, 79, 10.1054/plef.2000.0196 Rodriguez, 2001, Plasma membrane ganglioside sialidase regulates axonal growth and regeneration in hippocampal neurons in culture, J. Neurosci., 21, 8387, 10.1523/JNEUROSCI.21-21-08387.2001 Roghani, 2006, Time course of changes in passive avoidance and Y – maze performance in male diabetic rats, Iran. Biomed. J., 10, 99 Sachdeva, 2015, Naringin mitigate okadaic acid-induced cognitive impairment in an experimental paradigm of Alzheimer’s disease, J. Funct. Foods, 19, 110, 10.1016/j.jff.2015.08.024 Sachdeva, 2014, Naringin ameliorates memory deficits in experimental paradigm of Alzheimer’s disease by attenuating mitochondrial dysfunction, Pharmacol. Biochem. Behav., 127, 101, 10.1016/j.pbb.2014.11.002 Salvati, 2006, Polyunsaturated fatty acids and neurological diseases, Mini Rev. Med. Chem., 6, 1201, 10.2174/138955706778742740 Sharifi, 2011, FABP7 expression in normal and stab-injured brain cortex and its role in astrocyte proliferation, Histochem. Cell Biol., 136, 501, 10.1007/s00418-011-0865-4 Shimada, 2010, Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives, Chem. Res. Toxicol., 23, 1921, 10.1021/tx100286d Shuhama, 2007, Animal defense strategies and anxiety disorders, An. Acad. Bras. Cienc., 79, 97, 10.1590/S0001-37652007000100012 Sridhar, 2012, Development of flavones propargyl ethers as potent and selective inhibitors of cytochrome P450 enzymes 1A1 and 1A2, Drug Metab. Lett., 6, 275, 10.2174/1872312811206040007 Steiner, 2014, Dose-dependent benefits of quercetin on tumorigenesis in the C3(1)/SV40Tag transgenic mouse model of breast cancer, Cancer Biol. Ther., 15, 1456, 10.4161/15384047.2014.955444 Storch, 2008, The emerging functions and mechanisms of mammalian fatty acid-binding proteins, Annu. Rev. Nutr., 28, 73, 10.1146/annurev.nutr.27.061406.093710 Sweeny, 2000, Metabolism of the influenza neuraminidase inhibitor prodrug oseltamivir in the rat, Drug Metab. Dispos., 28, 737 Takahara, 2013, Electrophysiological effects of an anti-influenza drug oseltamivir on the guinea-pig atrium: comparison with those of pilsicainide, Biol. Pharm. Bull., 36, 1650, 10.1248/bpb.b13-00347 Toovey, 2008, Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review, Drug Saf., 31, 1097, 10.2165/0002018-200831120-00006 Uchiyama, 2015, Effect of adenosine system in the action of oseltamivir on behavior in mice, Neurosci. Lett., 599, 7, 10.1016/j.neulet.2015.05.014 Watanabe, 2007, Fabp7 maps to a quantitative trait locus for a schizophrenia endophenotype, PLoS Biol., 5, e297, 10.1371/journal.pbio.0050297 Xu, 2015, Protective effect of naringenin on glutamate-induced neurotoxicity in cultured hippocampal cells, Arch. Biol. Sci. Belgrade, 67, 639, 10.2298/ABS140811023X Yoshino, 2008, Oseltamivir (Tamiflu) increases dopamine levels in the rat medial prefrontal cortex, Neurosci. Lett., 438, 67, 10.1016/j.neulet.2008.04.011 Zaki, 2014, Naringenin protects against scopolamine-induced dementia in rats, Bull. Fac. Pharm. Cairo Univ., 52, 15, 10.1016/j.bfopcu.2013.11.001 Zbarsky, 2005, Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson’s disease, Free Radic. Res., 39, 1119, 10.1080/10715760500233113 Zeevalk, 2005, Mitochondrial inhibition and oxidative stress: reciprocating players in neurodegeneration, Antioxid. Redox Signal., 7, 1117, 10.1089/ars.2005.7.1117 Zhai, 1998, Comparative inhibition of human cytochromes P450 1A1 and 1A2 by flavonoids, Drug Metab. Dispos., 26, 989 Zhu, 2015, Qiangzhi decoction protects mice from influenza A pneumonia through inhibition of inflammatory cytokine storm, Chin. J. Integr. Med., 21, 376, 10.1007/s11655-014-2020-2